SciSure is a platform for managing laboratory operations end-to-end, built for scientific organizations. It brings together ELN, LIMS, and Health & Safety tools so teams can document experiments, track samples, manage chemical inventory, and maintain compliance workflows that are structured and audit-ready.
By replacing fragmented systems with a single governed platform, SciSure helps organizations improve reproducibility, gain clearer operational visibility, and scale lab operations with less risk.
Learn more

Gemini Enterprise Agent Platform is an advanced AI infrastructure from Google Cloud that enables organizations to build and manage intelligent agents at scale. As the evolution of Vertex AI, it consolidates model development, agent creation, and deployment into a unified platform. The system provides access to a diverse library of over 200 AI models, including cutting-edge Gemini models and leading third-party solutions. It supports both low-code and full-code development, giving teams flexibility in how they design and deploy agents. With capabilities like Agent Runtime, organizations can run high-performance agents that handle long-duration tasks and complex workflows. The Memory Bank feature allows agents to retain long-term context, improving personalization and decision-making. Security is a core focus, with tools like Agent Identity, Registry, and Gateway ensuring compliance, traceability, and controlled access. The platform also integrates seamlessly with enterprise systems, enabling agents to connect with data sources, applications, and operational tools. Real-time monitoring and observability features provide visibility into agent reasoning and execution. Simulation and evaluation tools allow teams to test and refine agents before and after deployment. Automated optimization further enhances agent performance by identifying issues and suggesting improvements. The platform supports multi-agent orchestration, enabling agents to collaborate and complete complex tasks efficiently. Overall, it transforms AI from a productivity tool into a fully autonomous operational capability for modern enterprises.
Learn more
NVIDIA PhysicsNeMo
NVIDIA's PhysicsNeMo is an open-source deep-learning framework built in Python that facilitates the design, training, fine-tuning, and inference of AI models that marry physical laws with data, thereby improving simulations, creating precise surrogate models, and enabling near-real-time predictions across a variety of domains such as computational fluid dynamics, structural mechanics, electromagnetics, weather forecasting, climate science, and digital twin technologies. It boasts robust GPU-accelerated performance and offers Python APIs based on the PyTorch framework, all distributed under the Apache 2.0 license, featuring a variety of pre-designed model architectures, including physics-informed neural networks, neural operators, graph neural networks, and generative AI methods, allowing developers to effectively harness the causal relationships present in physics along with empirical data for superior engineering modeling. Furthermore, PhysicsNeMo includes extensive training pipelines that cover all aspects from geometry ingestion to the implementation of differential equations, in addition to providing reference application recipes that assist users in rapidly kickstarting their development processes. This unique integration of powerful features positions PhysicsNeMo as a vital resource for engineers and researchers aiming to push the boundaries of physics-based AI applications. Overall, its capabilities make it a crucial asset for anyone looking to innovate in fields that rely on the intersection of artificial intelligence and physical modeling.
Learn more
BenevolentAI
BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.
Learn more